Xiaoniu Liang

2.5k total citations
85 papers, 1.6k citations indexed

About

Xiaoniu Liang is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, Xiaoniu Liang has authored 85 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Psychiatry and Mental health, 28 papers in Physiology and 27 papers in Neurology. Recurrent topics in Xiaoniu Liang's work include Dementia and Cognitive Impairment Research (31 papers), Parkinson's Disease Mechanisms and Treatments (23 papers) and Alzheimer's disease research and treatments (14 papers). Xiaoniu Liang is often cited by papers focused on Dementia and Cognitive Impairment Research (31 papers), Parkinson's Disease Mechanisms and Treatments (23 papers) and Alzheimer's disease research and treatments (14 papers). Xiaoniu Liang collaborates with scholars based in China, United States and Sweden. Xiaoniu Liang's co-authors include Qianhua Zhao, Qihao Guo, Jianfeng Luo, Wanqing Wu, Zhen Hong, Zhenxu Xiao, Ding Ding, Ding Ding, Li Zheng and Qiang Dong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of the American Geriatrics Society.

In The Last Decade

Xiaoniu Liang

81 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoniu Liang China 22 567 501 297 258 248 85 1.6k
Soichiro Shimizu Japan 23 567 1.0× 560 1.1× 328 1.1× 263 1.0× 136 0.5× 86 1.4k
Kristian Steen Frederiksen Denmark 24 636 1.1× 470 0.9× 205 0.7× 236 0.9× 110 0.4× 95 1.5k
Colin Groot Netherlands 21 897 1.6× 681 1.4× 177 0.6× 444 1.7× 188 0.8× 49 1.7k
Javier Olazarán Spain 28 1.1k 1.9× 456 0.9× 203 0.7× 304 1.2× 182 0.7× 108 2.1k
Catherine L. Gallagher United States 26 610 1.1× 623 1.2× 379 1.3× 406 1.6× 182 0.7× 74 1.9k
Yukihiko Washimi Japan 19 494 0.9× 424 0.8× 466 1.6× 353 1.4× 250 1.0× 55 1.6k
Thaı́s Minett United Kingdom 27 824 1.5× 575 1.1× 434 1.5× 374 1.4× 246 1.0× 72 2.1k
Simone Pomati Italy 23 653 1.2× 351 0.7× 283 1.0× 294 1.1× 99 0.4× 81 1.5k
Bryan K. Woodruff United States 20 666 1.2× 552 1.1× 428 1.4× 275 1.1× 280 1.1× 35 1.6k
Fu‐Chi Yang Taiwan 25 948 1.7× 360 0.7× 312 1.1× 284 1.1× 129 0.5× 156 2.0k

Countries citing papers authored by Xiaoniu Liang

Since Specialization
Citations

This map shows the geographic impact of Xiaoniu Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoniu Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoniu Liang more than expected).

Fields of papers citing papers by Xiaoniu Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoniu Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoniu Liang. The network helps show where Xiaoniu Liang may publish in the future.

Co-authorship network of co-authors of Xiaoniu Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoniu Liang. A scholar is included among the top collaborators of Xiaoniu Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoniu Liang. Xiaoniu Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shiyu, Fangyang Jiao, Tianyu Hu, et al.. (2025). Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson’s disease subtypes. npj Parkinson s Disease. 11(1). 54–54. 1 indexed citations
2.
Xu, Chao, Zhenxu Xiao, Xiaoniu Liang, et al.. (2024). Synergistic effect of smoking and education on incident dementia among older adults: The Shanghai aging study. SHILAP Revista de lepidopterología. 5(1). 100212–100212.
3.
Hu, Tianyu, Xiaoniu Liang, Shiyu Li, et al.. (2024). Disease progression in proposed brain-first and body-first Parkinson’s disease subtypes. npj Parkinson s Disease. 10(1). 111–111. 13 indexed citations
4.
Xiao, Zhenxu, Xiaoniu Liang, Jie Wu, et al.. (2024). Joint effect of testosterone and neurofilament light chain on cognitive decline in men: The Shanghai Aging Study. Alzheimer s & Dementia. 20(8). 5290–5298. 3 indexed citations
5.
Li, Xinyi, Yujie Yang, Fangyang Jiao, et al.. (2024). Rapid Cognitive Deterioration in Progressive Supranuclear Palsy: A 1‐Year Follow‐Up Study. Movement Disorders Clinical Practice. 12(4). 475–483. 1 indexed citations
6.
Liu, Su, Jianfeng Luo, Zhenxu Xiao, et al.. (2024). Low Intake of Total Antioxidant Nutrients as a Risk Factor for Incident Dementia in Older Adults: The Shanghai Aging Study. Neuroepidemiology. 59(5). 459–469. 1 indexed citations
7.
Liu, Fengtao, Jiaying Lu, Xinyi Li, et al.. (2023). 18F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy. European Journal of Nuclear Medicine and Molecular Imaging. 50(5). 1395–1405. 27 indexed citations
8.
Tang, Yilin, Xiaoniu Liang, Bo Shen, et al.. (2023). Heath management app use in Parkinson’s disease and quality of life during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 3(1). 23–23. 1 indexed citations
9.
Tang, Yilin, Linlin Han, Shiyu Li, et al.. (2023). Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia. npj Parkinson s Disease. 9(1). 23–23. 42 indexed citations
10.
Sun, Yi‐Min, Xinyue Zhou, Xiaoniu Liang, et al.. (2023). The genetic spectrum of a cohort of patients clinically diagnosed as Parkinson’s disease in mainland China. npj Parkinson s Disease. 9(1). 12 indexed citations
11.
12.
Wu, Lei, Shiyu Li, Yilin Tang, et al.. (2023). Quality of life: Seasonal fluctuation in Parkinson's disease. Frontiers in Neurology. 13. 1035721–1035721. 2 indexed citations
13.
Zhu, Zheng, Jie Wu, Zhenxu Xiao, et al.. (2022). Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer’s Disease: Shanghai Aging Study and Shanghai Memory Study. Nutrients. 14(19). 3959–3959. 51 indexed citations
14.
Liu, Fengtao, Xinyi Li, Jiaying Lu, et al.. (2022). 18F‐Florzolotau Tau Positron Emission Tomography Imaging in Patients with Multiple System Atrophy–Parkinsonian Subtype. Movement Disorders. 37(9). 1915–1923. 13 indexed citations
15.
Fan, Yun, Mengwei Zhang, Xiaoniu Liang, et al.. (2021). Determinants of quality of life in Parkinson’s disease: a perspective of novel clinical subtypes. Annals of Clinical and Translational Neurology. 8(11). 2174–2183. 3 indexed citations
16.
Ding, Ding, Feng Su, Wanqing Wu, et al.. (2021). Disturbed microbial ecology in Alzheimer’s disease: evidence from the gut microbiota and fecal metabolome. BMC Microbiology. 21(1). 226–226. 66 indexed citations
17.
Sun, Yi‐Min, Huiling Yu, Weixi Xiong, et al.. (2020). Disease Progression in Patients with Parkin‐Related Parkinson's Disease in a Longitudinal Cohort. Movement Disorders. 36(2). 442–448. 17 indexed citations
18.
Ding, Ding, et al.. (2020). Potential herb–drug interactions in community-dwelling older adults in China: the Shanghai Aging Study. Aging Clinical and Experimental Research. 32(12). 2677–2685. 7 indexed citations
19.
Zhu, Zheng, Yang Yang, Zhenxu Xiao, et al.. (2020). TOMM40 and APOE variants synergistically increase the risk of Alzheimer’s disease in a Chinese population. Aging Clinical and Experimental Research. 33(6). 1667–1675. 18 indexed citations
20.
Tang, Yilin, Kehu Yang, Jue Zhao, Xiaoniu Liang, & Jian Wang. (2019). Evidence of Repurposing Drugs and Identifying Contraindications from Real World Study in Parkinson’s Disease. ACS Chemical Neuroscience. 10(2). 954–963. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soichiro Shimizu Breakdown of academic impact, for papers by Kristian Steen Frederiksen Breakdown of academic impact, for papers by Colin Groot Breakdown of academic impact, for papers by Javier Olazarán Breakdown of academic impact, for papers by Catherine L. Gallagher Breakdown of academic impact, for papers by Yukihiko Washimi Breakdown of academic impact, for papers by Thaı́s Minett Breakdown of academic impact, for papers by Simone Pomati Breakdown of academic impact, for papers by Bryan K. Woodruff Breakdown of academic impact, for papers by Fu‐Chi Yang
Rankless by CCL
2026